ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
Thrombotic microangiopathies (TMAs) comprise a group of distinct disorders characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombosis. For many years distinction between these TMAs, especially between thrombotic thrombocytopenic purpura (TTP) and hemolytic ure...
Main Author: | Galit Sarig |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2014-10-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=436 |
Similar Items
-
Von Willebrand Factor and ADAMTS13 in COVID-19 and Beyond: A Question of Balance
by: Emmanuel J Favaloro, et al.
Published: (2021-07-01) -
Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine
by: Katerina Pavenski
Published: (2021-07-01) -
ADAMTS13 gene; a novel splicing site mutation in a case with thrombotic thrombocytopenic purpura
by: Sepideh Zununi Vahed, et al.
Published: (2021-05-01) -
Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
by: Martin Hausberg, et al.
Published: (2019-01-01) -
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
by: Mari R. Thomas, et al.
Published: (2015-08-01)